Safety and efficacy outcomes of first and second generation durable polymer...
This large network meta-analysis of randomised trials on drug eluting stents compares durable with biodegradable polymer stents and provides a clear visual ranking of the efficacy and safety of all of...
View ArticleBare metal stents, durable polymer drug eluting stents, and biodegradable...
According to this mixed treatment comparison meta-analysis, biodegradable polymer drug eluting stents are superior to first generation durable polymer drug eluting stents in reducing restenosis, but...
View ArticleSecondary prevention for patients after a myocardial infarction: summary of...
Acute management of people who have had a myocardial infarction (MI) has changed dramatically, with more people surviving. Katie Jones and colleagues summarise the most recent recommendations from the...
View ArticleFDA official: “clinical trial system is broken”
FDA investigator Thomas Marciniak has spoken out over drug companies and missing or “bad” data, most famously over rosiglitazone. He tells Deborah Cohen how he believes the current research and...
View ArticleCauses and patterns of readmissions in patients with common comorbidities:...
In this retrospective cohort study of 10 731 consecutive adult discharges from a medical department in Boston, the five most common primary diagnoses of potentially avoidable readmissions were usually...
View Article